Functional genomics: from genes to new therapies
Drug Discovery TodayPublished 1 March 1999
Mark R. Dyer, Dalia Cohen, Paul L. Herrling
Citations25
SJR quartileQ1
SJR score1.74
SNIP1.63
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
How functional genomics will offer significant opportunities in the search for causal and disease-modifying therapies for better treatment of society's most outstanding medical needs is described.
Abstract
The application of genomics in pharmaceutical R&D is presently one of the central issues in the industry. The evolution of functional genomics approaches and their integration into a technology platform for therapeutic discovery is a challenging and complex process. In this review, the authors describe how functional genomics will offer significant opportunities in the search for causal and disease-modifying therapies for better treatment of society's most outstanding medical needs.
Keywords
Computer ScienceBiochemistry, Genetics and Molecular Biology
ScienceMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
8,243 Citations1997Mihael H. Polymeropoulos, Christian Lavedan +18 more
A mutation was identified in the α-synuclein gene, which codes for a presynaptic protein thought to be involved in neuronal plasticity, in the Italian kindred and in three unrelated families of Greek origin with autosomal dominant inheritance for the PD phenotype.
ScienceDifferential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
5,041 Citations1992Peng Liang, Arthur B. Pardee
A method to separate and clone individual messenger RNAs (mRNAs) by means of the polymerase chain reaction using a set of oligonucleotide primers, one being anchored to the polyadenylate tail of a subset of mRNAs, the other being short and arbitrary in sequence so that it anneals at different positions relative to the first primer.
NeuronMechanisms of Neuronal Degeneration in Alzheimer's Disease
960 Citations1996Bruce A. Yankner
Although a consensus on the primary mechanism(s) of neuronal degeneration in AD has not yet been reached, several potential pathogenic mechanisms have emerged and the recent identification of new AD susceptibility genes promises to rapidly advance understanding of the primary neurodegenerative mechanisms.
New England Journal of MedicineGenetic Susceptibility to Asthma — Bronchial Hyperresponsiveness Coinherited with a Major Gene for Atopy
763 Citations1995Dirkje S. Postma, Eugene R. Bleecker +6 more
ScienceThe Human Genome Project: Past, Present, and Future
539 Citations1990James D. Watson
A summary of the current status of the organization and administration of the National Institutes of Health component of the human genome program and some prospects for the future directions of the program and the applications of genome information are presented.
Principles and practiceProteome Research: New Frontiers in Functional Genomics
479 Citations1997Marc R. Wilkins, Keith L. Williams +2 more
The present work focuses on the application of two-Dimensional Electrophoresis to Proteome Modelling and its applications in Clinical and Biomedical Applications of Proteomics.
NatureA first-generation physical map of the human genome
443 Citations1993Daniel Cohen, Ilya Chumakov +1 more
This work exhaustively analysed the CEPH yeast artificial chromosome library, which contains 33,000 clones, whose insert size was individually determined, and proposes a data analysis strategy that produces a first-generation integrated map covering most of the human genome.
ScienceShotgun Sequencing of the Human Genome
355 Citations1998J. Craig Venter, Mark D. Adams +4 more
Annual Review of MedicineGENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUS
214 Citations1996C. Ronald Kahn, David Vicent +1 more
New insights are expected in the near future from the systematic scanning of the genome for linkage with NIDDM, where mutations have been extensively searched in genes regulating insulin signaling and secretion.
Genome ResearchLarge-Scale Taxonomic Profiling of Eukaryotic Model Organisms: A Comparison of Orthologous Proteins Encoded by the Human, Fly, Nematode, and Yeast Genomes
162 Citations1998Arcady Mushegian, James R. Garey +2 more
Analysis of sequence substitutions and evolutionary distances in this data set revealed that most C. elegans genes are evolving more rapidly than Drosophila genes, suggesting that unequal evolutionary rates may contribute to the differences in similarity to human protein sequences.
NatureThe awakening of α-synuclein
92 Citations1997Michel Goedert
Researchers have identified a gene which, when mutated, is at least in part responsible for the condition — the mutation changes the amino acid alanine to threonine at a particular position in a protein called a-synuclein.
Drug Development ResearchProbing the genome for new drugs and targets with DNA arrays
12 Citations1997Jim Lillie
This review summarizes the opportunity presented by combining EST sequencing data with mRNA expression profiling with DNA arrays to find new ways of discovering drugs.
Drug Development ResearchBioinformatics in drug discovery
10 Citations1997David T. Kingsbury
It is estimated that when the Human Genome Project's DNA sequencing phase reaches it peak steady‐state, the production rate will be approximately 70 to 80 “new” genes each day, every day.